One2Treat’s Post

View organization page for One2Treat, graphic

1,332 followers

💡 𝟖𝟎𝟎 𝐩𝐫𝐨𝐟𝐞𝐬𝐬𝐢𝐨𝐧𝐚𝐥𝐬 joined the EFSPI (European Federation of Statisticians in the Pharmaceutical Industry) Regulatory Statistics Workshop in Basel to hear from One2Treat Founder Marc Buyse and Senior Trial Design Lead Samuel Salvaggio, PhD on “𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐏𝐫𝐨𝐜𝐞𝐝𝐮𝐫𝐞𝐬 𝐟𝐨𝐫 𝐌𝐮𝐥𝐭𝐢𝐩𝐥𝐞 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭𝐬 & 𝐎𝐮𝐭𝐜𝐨𝐦𝐞𝐬.”   🔍 Regulators challenged the team: “𝐇𝐨𝐰 𝐝𝐨 𝐲𝐨𝐮 𝐞𝐱𝐩𝐥𝐚𝐢𝐧 𝐭𝐡𝐢𝐬 (𝐭𝐡𝐞 𝐍𝐞𝐭 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐁𝐞𝐧𝐞𝐟𝐢𝐭) 𝐭𝐨 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬?”   Marc responded with a smile: “𝐇𝐚𝐯𝐞 𝐲𝐨𝐮 𝐞𝐯𝐞𝐫 𝐭𝐫𝐢𝐞𝐝 𝐞𝐱𝐩𝐥𝐚𝐢𝐧𝐢𝐧𝐠 𝐭𝐡𝐞 𝐡𝐚𝐳𝐚𝐫𝐝 𝐫𝐚𝐭𝐢𝐨 𝐭𝐨 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬?” 😎   Curious about the Net Treatment Benefit and how it can make clinical outcomes easier to understand? 👉 Visit our website or get in touch to learn more: www.one2treat.com   #ClinicalTrials #Statistics #EFSPI

To view or add a comment, sign in

Explore topics